{
    "title": "Gilead targets 2 mln remdesivir courses by year-end",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8448505/Gilead-targets-2-mln-remdesivir-courses-year-end.html",
    "date": "2020-06-22",
    "keywords": [
        "remdesivir",
        "drug",
        "company",
        "supply",
        "gilead",
        "monday",
        "target",
        "easiertouse",
        "version",
        "forefront",
        "fight",
        "virus",
        "recovery",
        "trial",
        "respiratory",
        "illness",
        "world",
        "worldwide",
        "executive",
        "officer",
        "daniel",
        "oday",
        "statement",
        "httpsbitly3eqpej9",
        "cipla",
        "ltd",
        "sunday",
        "approval",
        "country",
        "hetero",
        "treatment",
        "milligram",
        "dose",
        "price",
        "course",
        "analyst",
        "wave",
        "formulation",
        "nebulizer",
        "use",
        "bengaluru",
        "editing",
        "koyyur",
        "saumyadeb",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}